Credit Suisse and Canaccord Genuity are the joint bookrunning managers
By Devika Patel
Knoxville, Tenn., July 16 – BioAmber Inc. said it priced a $33.6 million public sale of its common stock with a $5.04 million greenshoe. The deal was announced Tuesday.
The company will sell 2.8 million common shares at $12.00 apiece. The price per share is a 15.55% discount to the July 15 closing share price of $14.21.
Credit Suisse Securities (USA) LLC and Canaccord Genuity Inc. are the joint bookrunning managers.
Settlement is expected July 21.
Proceeds will be used for working capital and other general corporate purposes.
The chemicals company is based in Minneapolis.
| Issuer: | BioAmber Inc.
|
| Issue: | Common stock
|
| Amount: | $33.6 million
|
| Greenshoe: | $5.04 million
|
| Shares: | 2.8 million
|
| Price: | $12.00
|
| Warrants: | No
|
| Bookrunners: | Credit Suisse Securities (USA) LLC and Canaccord Genuity Inc.
|
| Announcement date: | July 15
|
| Pricing date: | July 16
|
| Settlement date: | July 21
|
| Stock symbol: | NYSE: BIOA
|
| Stock price: | $14.21 at close July 15
|
| Market capitalization: | $227.42 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
